180 related articles for article (PubMed ID: 29396402)
1. Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Zheng Y; Sethi R; Mangala LS; Taylor C; Goldsmith J; Wang M; Masuda K; Carrami EM; Mannion D; Miranda F; Herrero-Gonzalez S; Hellner K; Chen F; Alsaadi A; Albukhari A; Fotso DC; Yau C; Jiang D; Pradeep S; Rodriguez-Aguayo C; Lopez-Berestein G; Knapp S; Gray NS; Campo L; Myers KA; Dhar S; Ferguson D; Bast RC; Sood AK; von Delft F; Ahmed AA
Nat Commun; 2018 Feb; 9(1):476. PubMed ID: 29396402
[TBL] [Abstract][Full Text] [Related]
2. Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction.
Lin PC; Chan PM; Hall C; Manser E
J Biol Chem; 2011 Dec; 286(48):41466-41478. PubMed ID: 21953449
[TBL] [Abstract][Full Text] [Related]
3. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
[No Abstract] [Full Text] [Related]
5. Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.
Yu Y; Gaillard S; Phillip JM; Huang TC; Pinto SM; Tessarollo NG; Zhang Z; Pandey A; Wirtz D; Ayhan A; Davidson B; Wang TL; Shih IeM
Cancer Cell; 2015 Jul; 28(1):82-96. PubMed ID: 26096845
[TBL] [Abstract][Full Text] [Related]
6. Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications.
Li S; Zhang J; Zhang J; Li J; Cheng L; Chen L; Cha C; Guo G
CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):249-265. PubMed ID: 33109053
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling.
Garza JC; Qi X; Gjeluci K; Leussis MP; Basu H; Reis SA; Zhao WN; Piguel NH; Penzes P; Haggarty SJ; Martens GJ; Poelmans G; Petryshen TL
Transl Psychiatry; 2018 Jul; 8(1):135. PubMed ID: 30046097
[TBL] [Abstract][Full Text] [Related]
8. Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
Ahmed AA; Wang X; Lu Z; Goldsmith J; Le XF; Grandjean G; Bartholomeusz G; Broom B; Bast RC
Cancer Res; 2011 Sep; 71(17):5806-17. PubMed ID: 21775522
[TBL] [Abstract][Full Text] [Related]
9. CNP/cGMP signaling regulates axon branching and growth by modulating microtubule polymerization.
Xia C; Nguyen M; Garrison AK; Zhao Z; Wang Z; Sutherland C; Ma L
Dev Neurobiol; 2013 Sep; 73(9):673-87. PubMed ID: 23420620
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for CRMP2-induced axonal microtubule formation.
Niwa S; Nakamura F; Tomabechi Y; Aoki M; Shigematsu H; Matsumoto T; Yamagata A; Fukai S; Hirokawa N; Goshima Y; Shirouzu M; Nitta R
Sci Rep; 2017 Sep; 7(1):10681. PubMed ID: 28878401
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
[TBL] [Abstract][Full Text] [Related]
12. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N
Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769
[TBL] [Abstract][Full Text] [Related]
13. The Fer tyrosine kinase regulates an axon retraction response to Semaphorin 3A in dorsal root ganglion neurons.
Shapovalova Z; Tabunshchyk K; Greer PA
BMC Dev Biol; 2007 Nov; 7():133. PubMed ID: 18053124
[TBL] [Abstract][Full Text] [Related]
14. CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration.
Morales X; Peláez R; Garasa S; Ortiz de Solórzano C; Rouzaut A
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680167
[TBL] [Abstract][Full Text] [Related]
15. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.
Xu W; Ge Y; Liu Z; Gong R
J Biol Chem; 2015 Jan; 290(3):1348-63. PubMed ID: 25468908
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HSP27 phosphorylation induced by microtubule interfering agents: implication of p38 signalling pathway.
Casado P; Zuazua-Villar P; Prado MA; Valle ED; Iglesias JM; Martínez-Campa C; Lazo PS; Ramos S
Arch Biochem Biophys; 2007 May; 461(1):123-9. PubMed ID: 17367746
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
[TBL] [Abstract][Full Text] [Related]
20. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC
J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
